Disclosure Of Entity's Operating Segments [Text Block]

Captor Therapeutics S.A. - Filing #6064395

Concept	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of entity's operating segments [text block]	—	13.22	—	—
Disclosure of operating segments [text block]	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	15 825 PLN	—	13 201 PLN
Interest income	—	1 044 PLN	—	3 083 PLN
Tax expense (income)	—	0 PLN	—	57,000 PLN
Profit (loss) before tax	—	38 426 PLN	—	70 527 PLN
Profit (loss) from continuing operations	—	38 426 PLN	—	70 584 PLN
Profit (loss)	—	38 426 PLN	—	70 584 PLN
Assets	87 497 PLN	—	97 294 PLN	—
Liabilities	23 023 PLN	—	28 074 PLN	—
Cash flows from (used in) operating activities	—	31 878 PLN	—	52 204 PLN
Cash flows from (used in) investing activities	—	273,000 PLN	—	19 931 PLN
Cash flows from (used in) financing activities	—	4 842 PLN	—	36 941 PLN
Disclosure of products and services [text block]	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]